Exalenz Bioscience

Exalenz Bioscience is a medical technology company that specializes in the development and commercialization of advanced diagnostic systems for gastrointestinal (GI) and liver diseases. The company's flagship product, the BreathID System, is a non-invasive, point-of-care system that uses breath testing to diagnose and monitor various GI and liver conditions.

History

Exalenz Bioscience was founded in 2006 in Israel, with the aim of developing innovative diagnostic solutions for GI and liver diseases. The company's founders recognized the need for non-invasive, accurate, and easy-to-use diagnostic tools in these areas of medicine.

Products

The company's main product, the BreathID System, is a breath test-based diagnostic system. It uses 13C urea breath test technology to diagnose and monitor conditions such as Helicobacter pylori infection, gastric ulcer, and liver cirrhosis. The BreathID System is known for its high accuracy, ease of use, and non-invasiveness.

Research and Development

Exalenz Bioscience is committed to continuous research and development. The company collaborates with leading medical institutions worldwide to conduct clinical trials and develop new applications for its technology.

Recognition

Exalenz Bioscience has received numerous awards and recognitions for its innovative technology. These include the Medical Device Excellence Awards and the Frost & Sullivan Product Innovation Award.

See Also

• Breath test
• Gastroenterology
• Liver disease